David S. Schilansky
Founder at One Biosciences SAS
David S. Schilansky active positions
Companies | Position | Start | End |
---|---|---|---|
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | Founder | 2020-06-30 | - |
Chairman | - | - | |
Chief Executive Officer | 2020-06-30 | - | |
Home Biosciences SAS
Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Chief Executive Officer | 2018-12-31 | - |
Chairman | 2018-12-31 | - | |
Founder | 2018-12-31 | - |
Career history of David S. Schilansky
Former positions of David S. Schilansky
Companies | Position | Start | End |
---|---|---|---|
LYSOGENE | Director/Board Member | 2016-11-22 | 2022-06-23 |
Independent Dir/Board Member | 2016-11-22 | 2022-06-23 | |
DBV TECHNOLOGIES | Chief Administrative Officer | 2011-12-18 | 2015-01-07 |
Comptroller/Controller/Auditor | 2014-09-21 | 2015-01-07 | |
Chief Operating Officer | 2015-01-07 | - | |
Director of Finance/CFO | 2011-12-18 | - | |
Public Communications Contact | 2011-12-18 | 2015-01-07 | |
IPSEN | Director of Finance/CFO | 2005-12-31 | 2011-11-30 |
Public Communications Contact | 2005-12-31 | 2011-11-30 | |
Vantiva Usa Shared Services, Inc.
Vantiva Usa Shared Services, Inc. Electronics/AppliancesConsumer Durables Technicolor USA, Inc. manufactures and sells electronic products. It offers wide selection of radio, television, tablets, smart phones, laptop, home accessories, portable audio, and computer products. The company was founded in 1919 and is headquartered in Indianapolis, IN. | Investor Relations Contact | 2002-12-31 | - |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Director of Finance/CFO | - | - |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Public Communications Contact | 2010-08-24 | - |
Ipsen International GmbH
Ipsen International GmbH Industrial MachineryProducer Manufacturing Ipsen International GmbH manufactures and distributes furnaces and plant systems. Its products include sealed quench furnaces; chamber and multi-purpose chamber furnaces; horizontal and vertical furnaces; EcoFire system; HydroNit Sensor; HybridCarb; and EndoSave system. The firm also provides software processes such as Carb-o-Prof 4.0, AutoMag, Vacu-Prof, and Conti-Control. The company was founded by Harold Ipsen in 1957 and is headquartered in Kleve, Germany. | Public Communications Contact | 2009-05-21 | - |
Training of David S. Schilansky
Imperial College London | Graduate Degree |
Université Paris Dauphine-PSL | Graduate Degree |
Statistics
International
France | 8 |
United States | 3 |
United Kingdom | 2 |
Operational
Public Communications Contact | 4 |
Director of Finance/CFO | 3 |
Graduate Degree | 2 |
Sectoral
Health Technology | 7 |
Consumer Services | 3 |
Producer Manufacturing | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
IPSEN | Health Technology |
DBV TECHNOLOGIES | Health Technology |
LYSOGENE | Commercial Services |
Private companies | 6 |
---|---|
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Ipsen International GmbH
Ipsen International GmbH Industrial MachineryProducer Manufacturing Ipsen International GmbH manufactures and distributes furnaces and plant systems. Its products include sealed quench furnaces; chamber and multi-purpose chamber furnaces; horizontal and vertical furnaces; EcoFire system; HydroNit Sensor; HybridCarb; and EndoSave system. The firm also provides software processes such as Carb-o-Prof 4.0, AutoMag, Vacu-Prof, and Conti-Control. The company was founded by Harold Ipsen in 1957 and is headquartered in Kleve, Germany. | Producer Manufacturing |
Vantiva Usa Shared Services, Inc.
Vantiva Usa Shared Services, Inc. Electronics/AppliancesConsumer Durables Technicolor USA, Inc. manufactures and sells electronic products. It offers wide selection of radio, television, tablets, smart phones, laptop, home accessories, portable audio, and computer products. The company was founded in 1919 and is headquartered in Indianapolis, IN. | Consumer Durables |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Ipsen Pharma SAS is a biopharmaceutical company that develops medicines in oncology, neuroscience and rare diseases. The company was founded by Henri Beaufour in 1929 and is headquartered in Boulogne-Billancourt, France. | Health Technology |
One Biosciences SAS
One Biosciences SAS BiotechnologyHealth Technology One Biosciences SAS engages in single-cell technology research and development activities. It aims to identify new therapeutics for difficult-to-treat diseases. The company was founded by Céline Vallot, Magali Richard, and David Schilansky and is headquartered in Paris, France. | Health Technology |
Home Biosciences SAS
Home Biosciences SAS BiotechnologyHealth Technology Home Biosciences SAS is a biotech venture builder that partners with academics and scientists to develop life-changing therapies for patients. The company is based in France and has subsidiaries in the country. The French company's operating model allows its teams to focus on scientific and operational excellence to expedite and de-risk the discovery and development paths of its projects, which are housed in dedicated ventures and fully financed by Home Biosciences. Home Biosciences was founded in 2019 by Magali Richard and David S. Schilansky, who has been the CEO since its inception. | Health Technology |
- Stock Market
- Insiders
- David S. Schilansky
- Experience